Lawrence Samelson

Lawrence Samelson receives Cancer Research Institute Coley Award

Sep 30, 2019

Lawrence Samelson, M.D., Chief of the Laboratory of Cellular and Molecular Biology, was named a recipient of the Cancer Research Institute’s 2019 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology. The award recognizes scientists for their seminal discoveries in the fields of basic and tumor immunology.  Read more...

Marston Linehan

Marston Linehan discusses kidney cancer breakthroughs with the Federal News Network podcast

Sep 30, 2019

Marston Linehan, M.D., Chief of the Urologic Oncology Branch, was recently featured on the Federal News Network podcast. During the episode, Dr. Linehan discussed how kidney cancer is not a single disease but rather a number of different cancers that all happen to occur in the kidney. He also discussed how human genetics research has led to advances in kidney cancer, such as discovering that there are multiple genes that cause 17 types of kidney cancer. He says that while there has been much progress, much work is still left to do. Read more...

Doug Lowy and John Schiller

The New York Times highlights the importance of physician-scientists

Sep 27, 2019

The New York Times recently posted an editorial highlighting the importance of physician-scientists in the medical field. The article cited several examples of discoveries made by physician-scientists that have changed the history of medicine, including the development of the HPV vaccine by Doug Lowy, M.D., Chief of the Laboratory of Cellular Oncology (LCO), and John Schiller, Ph.D., Deputy Chief of LCO. Read more...

Karlyne Reilly

Karlyne Reilly discusses childhood cancer on BioMedCentral

Sep 16, 2019

Karlyne M. Reilly, Ph.D., Senior Associate Scientist in the Pediatric Oncology Branch, recently wrote a blog for BioMedCentral. In the blog, Dr. Reilly addresses both the difficulties and the importance of accessing and collecting data from childhood cancer clinical trials and initiatives, such as MyPART, to help improve childhood cancer research in the future.  Read more...

NIH IRP Speaking of Science

Michael Gottesman and Ira Pastan featured in NIH Intramural Research Program podcast

Sep 12, 2019

Michael Gottesman, M.D., Chief of the Laboratory of Cell Biology, and Ira Pastan, M.D., Co-Chief of the Laboratory of Molecular Biology, were recently featured in the NIH IRP podcast Speaking of Science. In the podcast, Dr. Gottesman and Dr. Pastan discussed how their research and discoveries have helped effectively treat cancer in order to improve and save potentially millions of lives.  Read more...

Lori Wiener

Lori Wiener selected as NYU Alumni Changemaker

Sep 10, 2019

Lori Wiener, Ph.D., DCSW, LCSW-C, Senior Associate Scientist in the Pediatric Oncology Branch, has been selected as a 2019 NYU Alumni Changemaker. Changemakers are selected by the NYU Alumni Association Board for their ability to reduce suffering, bring hope to the marginalized and save lives.  Read more...

Steve Rosenberg

Steve Rosenberg receives 2019 Edogawa NICHE Prize

Sep 4, 2019

Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, has received the 2019 Edogawa NICHE Prize. Dr. Rosenberg was recognized for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells, which has heralded the birth of a new chapter in the fight against cancer. Read more...

James Kochenderfer

James Kochenderfer named finalist for 2019 FNIH Trailblazer Prize for Clinician-Scientists

Sep 4, 2019

James N. Kochenderfer, M.D., Investigator in the Surgery Branch, has been selected as a finalist for the Foundation for the National Institutes of Health (FNIH) Trailblazer Prize for Clinician-Scientists. He is nominated for developing immunotherapies that leverage chimeric antigen receptor (CAR) T cells to treat blood cancers, including lymphoma and multiple myeloma. The winner of the Trailblazer Prize will be announced October 23, 2019. Read more...

Tim Greten, M.D.

Clinical Trial Conversation: Tim Greten describes primary liver cancer clinical trial

Sep 3, 2019

Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer that is very difficult to treat, and patients live an average of six to nine months after diagnosis. Tim Greten, M.D., Deputy Chief of the Thoracic and GI Malignancies Branch, is leading a new clinical trial to determine whether administering the antibiotic vancomycin in combination with the drugs nivolumab and tadalafil will lead to cancer regression in patients with liver metastasis or primary HCC. Read more...

Bill Telford

Bill Telford receives 2019 International Society for the Advancement of Cytometry Distinguished Service Award

Sep 3, 2019

Bill Telford, Ph.D., Senior Associate Scientist in the Experimental Transplantation and Immunology Branch, has received the 2019 International Society for the Advancement of Cytometry (ISAC) Distinguished Service Award. The award honors individuals who served ISAC in a major role, provided major support to ISAC and its members or made a significant contribution to the success of ISAC. Read more...